Guidelines Webinars/Videos

Prof. Chiang discusses Atherosclerotic Cardiovascular Disease (ASCVD) in context of cumulated LDL exposure, and the different stages of secondary prevention and how starting to manage the disease at a younger age or earlier stage is beneficial. At 41:12 he answers audience questions.

First published: October 25, 2023  

In this second part of the Round Table conversation, the Editorial Panel discuss how showing patients’ images of their plaques help with adherence, discuss other targets such as Lp (a) and triglycerides and most importantly, discuss some of the latest data from the recently concluded ESC congress.

Prof. Christopher P. Cannon, Prof. Chern-En Chiang, Prof. Stephen Nicholls, Prof. S. Lale Tokgözoğlu, Prof. Deepak Bhatt

First published: September 1, 2023  

In recognition of the ASCVD & Lipidology Knowledge Hub 2 year anniversary, the esteemed faculty members for this educational resource site met to discuss the hot topics that have occurred over this time. Come and take a seat at this roundtable discussion with Prof. Christopher P. Cannon, Prof. Chern-En Chiang, Prof. Stephen Nicholls, Prof. S. Lale Tokgözoğlu, and Prof. Deepak Bhatt as they discuss target guidelines, dosing, and compliance in lipid lowering therapies.

Prof. Christopher P. Cannon, Prof. Chern-En Chiang, Prof. Stephen Nicholls, Prof. S. Lale Tokgözoğlu, Prof. Deepak Bhatt

First published: August 1, 2023  

In this video, we summarize the results from the SANTORINI trial which documents the effectiveness of current treatment practice in managing LDL-C levels for patients in the higher CV risk categories in and how care may be improved.

First published: July 12, 2023  

Prof. Christopher Cannon discusses insights obtained from the GOULD study on how lipids are managed in real-world clinical practice among patients with atherosclerotic cardiovascular disease (ASCVD).

This webinar recording is designed for health care professionals (cardiologists, endocrinologists, lipidogists, diabetes specialists, neurologists) who are interested in learning more on the latest research, treatment, and clinical management of patients with a history and risk of ASCVD.

Prof. Christopher Cannon

First published: June 6, 2023  

In this talk, Prof. Lale Tokyozoglu comprehensively summarizes the latest research and clinical updates in ASCVD and Lipidology from the last year.

Prof. Lale Tokyozoglu

First published: March 27, 2023  

In this KOL master class on demand video Prof. Samer Ellahham discusses the secondary prevention of acute coronary syndrome (ACS). He is joined by Prof. Hani Sabbour for a peer-to-peer discussion and to answer audience questions.

This interactive webinar is designed for health care professionals (cardiologists, endocrinologists, lipidologists, neurologists) who are interested in learning more on the latest research, treatment, and clinical management of patients with acute coronary syndrome.

Prof. Samer Ellahham, Prof. Hani Sabbour

First published: February 28, 2023  

A Peer-to-Peer Discussion

In this specially compiled video, Dr. Carl Orringer, a past president of the National Lipid Association (NLA), shares his views on the recently published NLA Scientific Statement on Lipid Measurements in the Management of Cardiovascular Diseases in a conversation with our Editorial Panel Member, Prof. Lale Tokgözoğlu. The experts discuss the importance of these lipoprotein measurements to clinicians and other healthcare professionals providing treatment and the importance of shared decision making (SDM) in improving patient care.

Prof. Lale Tokgözoğlu, Dr. Carl Orringer

First published: October 21, 2021  

A comprehensive summary of the highlights from ESC Congress 2021 in ASCVD and lipidology. In this specially compiled video, Professor Cannon and Professor Bhatt share their views on the late breaker results from REDUCE-IT and OMENI trials, along with the update ESC prevention guidelines.

Christopher Cannon, MD & Dr. Deepak L. Bhatt MD, MPH

First published: September 16, 2021  

In this second video from the ESC 2021, Professor Cannon and Professor Nicholls discuss late-breaking results from the HUGYENs trial on evolcoumab, as well as the ESC prevention guidelines and the impact of the NHS approval of Inclisiran in improving patient care.

Christopher Cannon, MD & Professor Stephen Nicholls, MBBS, Ph.D., FRACP, FACC, FESC, FAHA, FCSANZ, FAHMS

First published: September 15, 2021